These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies. Geerlings SE; Beerepoot MA; Prins JM Infect Dis Clin North Am; 2014 Mar; 28(1):135-47. PubMed ID: 24484580 [TBL] [Abstract][Full Text] [Related]
11. [Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine]. Prát V; Matousovic K; Horcicková M; Hatala M; Milotová Z Cas Lek Cesk; 1989 Aug; 128(35):1106-9. PubMed ID: 2605612 [TBL] [Abstract][Full Text] [Related]
12. [Candidate vaccine against urinary tract infections]. Hoepelman IM; Meiland R; Langermann S Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1860-2. PubMed ID: 11593791 [TBL] [Abstract][Full Text] [Related]
13. [Vaccinations in recurrent urinary tract infections--an observation study relating to health economy]. Lenk VS; Dorsch B Aktuelle Urol; 2009 Nov; 40(6):360-5. PubMed ID: 19899016 [TBL] [Abstract][Full Text] [Related]
14. [Use of vaccines for prophylaxis of urinary tract infections]. Carraro-Eduardo JC; Gava IA J Bras Nefrol; 2012 Jun; 34(2):178-83. PubMed ID: 22850920 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of urinary tract infections with SolcoUrovac]. Litschgi M Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132 [TBL] [Abstract][Full Text] [Related]
16. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin. Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163 [TBL] [Abstract][Full Text] [Related]
17. [Protective effect of coli-proteus vaccine in an experimental animal model]. Bĕlohlávek S; Konícková L Cesk Farm; 1980 May; 29(3-4):95-9. PubMed ID: 6996844 [No Abstract] [Full Text] [Related]
18. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections. Ha US; Cho YH Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471 [TBL] [Abstract][Full Text] [Related]
19. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718 [TBL] [Abstract][Full Text] [Related]
20. [Effects of vaccination in urinary infections caused by Escherichia coli in rats]. Mathieu D; Jacques L; Auer J; Bizzini B Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]